Results 11 to 20 of about 54,526,142 (249)

Interleukin-35 and Thymoquinone nanoparticle-based intervention for liver protection against paracetamol-induced liver injury in rats. [PDF]

open access: yesSaudi J Biol Sci, 2023
Paracetamol (PAR) is a commonly used antipyretic and analgesic agent, but its excessive usage can induce liver damage and major health consequences.
Abduh MS   +6 more
europepmc   +2 more sources

Serum interleukin-35 and pentraxin-3 levels in patients with mild acute pancreatitis

open access: yesGastroenterology Review, 2019
Introduction Interleukin-35 (IL-35) is a newly defined potent anti-inflammatory cytokine that is predominantly produced by regulatory T cells, and pentraxin-3 belongs to the acute-phase proteins.
Evrim Aksoy   +5 more
doaj   +2 more sources

Expression of interleukin-35 and type 2 cytokines in children with acute allergic asthma [PDF]

open access: yesIranian Journal of Immunology, 2021
Background: Allergic asthma is believed to be a T helper 2 cell (Th2) preponderant response caused by airway hyper-responsiveness. Interleukin-35 (IL-35) is a newly discovered anti-inflammatory cytokine.
Zhangqiao Cai, Xuxia He, Jing Yang
doaj   +1 more source

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies [PDF]

open access: yes, 2012
BACKGROUND: Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6 receptor (IL6R) signalling propagates downstream inflammation cascades.
Thomas, GN   +489 more
core   +4 more sources

Interleukin-35 Levels in Patients with Stable Coronary Artery Disease

open access: yes, 2022
Background It has been shown that interleukin-35 (IL-35) subunits are strongly expressed in atherosclerotic plaques in humans. Therefore, it is considered to play a role in atherosclerosis. Objectives In this study, IL-35 levels were compared with the
Bulent Demir (12698615)   +7 more
core   +1 more source

Interleukin-35 Suppresses Interleukin-9-Secreting CD4+ T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma

open access: yesFrontiers in Immunology, 2021
Chronic hepatitis B virus (HBV) infection induces dysfunction of immune response and chronic liver damage. However, the mechanisms that account for HBV-related hepatocellular carcinoma (HCC) are poorly understood.
Qian Zhang   +4 more
doaj   +1 more source

Effect of nonsurgical periodontal therapy on interleukin-35 level in gingival crevicular fluid

open access: yesSRM Journal of Research in Dental Sciences, 2023
Background: Clinical attachment level (CAL), alveolar bone loss, and periodontal pockets constitute the major signs of periodontitis. The interaction between the host and the bacteria that forms a biofilm on the tooth surface is one of the major ...
Ashwini Jadhav   +3 more
doaj   +1 more source

Increased Interleukin-35 suppresses peripheral CD14+ monocytes function in patients with Kawasaki disease

open access: yesBMC Immunology, 2020
Background Interleukin-35 (IL-35) is a newly identified IL-12 cytokine family member, which regulates the activity of immune cells in infectious diseases and autoimmune disorders.
Haijian Xing, Gang Tian
doaj   +1 more source

Interleukin-18 [PDF]

open access: yes, 2003
Interleukin-18 (IL-18), a recently described member of the IL-1 cytokine superfamily, is now recognized as an important regulator of innate and acquired immune responses.
McInnes, I.B.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy